{"id":"W2115961074","doi":"10.1158/1078-0432.ccr-14-1760","title":"The Neoadjuvant Model Is Still the Future for Drug Development in Breast Cancer","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":92,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"National Center for Advancing Translational Sciences; National Cancer Institute","keywords":"Lapatinib; Medicine; Trastuzumab; Breast cancer; Oncology; Clinical trial; Internal medicine; Neoadjuvant therapy; Cancer; Clinical endpoint; Surrogate endpoint; Regimen; Hazard ratio; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.04894222,0.0002367031,0.0007173843,0.00006017695,0.000378482,0.0001402284,0.001451911,0.0002829439,0.0001588135],"category_scores_gemma":[0.05026502,0.0001189732,0.0002143978,0.0005222601,0.0009668457,0.00006206922,0.0005708784,0.001862537,0.00003861993],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004793313,"about_ca_system_score_gemma":0.002736056,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000193858,"about_ca_topic_score_gemma":0.00160146,"domain_scores_codex":[0.992092,0.002693349,0.001887435,0.0007172502,0.001567031,0.001042943],"domain_scores_gemma":[0.8953916,0.1015877,0.0002466656,0.0009510641,0.001360068,0.0004628959],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","study_design_scores_codex":[0.002723078,0.0004016597,0.003366494,0.0001326442,0.0001500734,0.000006602229,0.001763669,0.0001092385,0.000004241781,0.04361273,0.5091984,0.4385312],"study_design_scores_gemma":[0.002609438,0.00007550116,0.001954866,0.0001817857,0.00003259766,0.000001159466,0.0006921169,0.0119881,0.0000780386,0.8389921,0.1431608,0.0002335621],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"methods","genre_scores_codex":[0.2039772,0.01266749,0.04480796,0.7022912,0.01443991,0.01578466,0.00267754,0.0002870779,0.003066943],"genre_scores_gemma":[0.1510123,0.01591886,0.7584073,0.01206487,0.02037698,0.01848452,0.000007911376,0.0005045213,0.02322275],"genre_candidate":"methods","genre_consensus":null,"teacher_disagreement_score":0.7953793,"threshold_uncertainty_score":0.9793141,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.8736747486636635,"score_gpt":0.7238382028301892,"score_spread":0.1498365458334743,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}